Creative Biolabs delivers custom microfluidic cell encapsulation solutions that combine precision chip engineering with cell-centric assay design. Built on droplet microfluidics, hydrogel microgel formation, and modular on-chip unit operations, our solutions help you encapsulate single cells or defined cell numbers into monodisperse compartments.
In the vanguard of precision medicine and advanced biotechnology, the resolution of biological analysis has shifted from bulk population averages to the granularity of individual cells. Creative Biolabs offers comprehensive custom microfluidic cell encapsulation solutions. By leveraging state-of-the-art droplet microfluidics, we enable the high-throughput compartmentalization of single cells, organoids, and biological agents into monodisperse picoliter-scale droplets or hydrogel microparticles.
Our multidisciplinary team of microfluidic engineers, material scientists, and biologists works closely with clients to design bespoke chips, optimize hydrogel formulations, and validate downstream assays, ensuring that every droplet generated contributes meaningful data to your research.
Creative Biolabs offers a modular service structure. Clients can engage us for specific stages of the workflow or for a full turnkey solution.
This is the foundational service for omics and screening applications. We encapsulate individual cells into aqueous droplets surrounded by an inert fluorinated oil phase.
For applications requiring a solid or semi-solid scaffold (e.g., 3D culture, flow cytometry sorting), we encapsulate cells into hydrogel precursors that are crosslinked on-chip or off-chip.
Standard water-in-oil droplets cannot be analyzed by traditional FACS machines due to the insulating oil shell. We generate double emulsions where the oil droplet is suspended in an outer aqueous carrier phase.
We transform droplets into picoliter micro-reactors to screen for function, not just phenotype.
Our virus encapsulation services focus on maintaining structural integrity and infectivity (where applicable) while enhancing handling safety and experimental reproducibility.
Off-the-shelf chips often fail to meet specific experimental requirements. We operate a dedicated soft lithography foundry.
The success of cell encapsulation relies heavily on the choice of biomaterials. Creative Biolabs provides a vast library of matrix options.
| Material | Crosslinking Mechanism | Key Features | Recommended Application |
| Alginate | Ionic (Ca2+, Ba2+) | Biocompatible, reversible, perm-selective | Cell Therapy (Islets), Immunoisolation |
| GelMA | Photo (UV/Visible + Initiator) | Bioactive sequences (RGD), tunable stiffness | Tissue Engineering, 3D Cancer Models |
| PEG-DA | Photo (UV + Initiator) | Bio-inert, highly defined structure, reproducible | Stem Cell Differentiation, Mechanobiology |
| Agarose | Thermal (Cooling) | No chemical crosslinkers, high viability | Single Cell Cultivation, FACS Sorting |
| Hyaluronic Acid | Photo or Chemical | Native ECM component, supports signaling | Cartilage Repair, Stem Cell Niche studies |
| Fibrin | Enzymatic (Thrombin) | Natural clotting material, promotes angiogenesis | Wound Healing, Vascularization studies |
Below is a typical engagement flow for custom cell encapsulation solutions.
The applications of our custom microfluidic encapsulation services are vast and continually expanding.
Encapsulation enables local accumulation of secreted molecules, turning low-abundance secretion events into measurable signals—especially useful when bulk assays dilute signals below detection.
Microgels support controlled diffusion and structural context. In many workflows, microgels also make recovery and handling more straightforward than fragile droplets during longer incubations.
Droplet microfluidics has been used broadly to enable high-throughput assay formats and improved screening throughput compared with conventional approaches.
Droplet microfluidics continues to expand for advanced single-cell analysis strategies and integrated workflows, with active development across encapsulation methods.
"Creative Biolabs helped us transition to droplet-based single-cell encapsulation with a workflow that remained stable during incubation. The biggest difference was the practicality—clear operating windows, stability checkpoints, and recovery guidance that our team could follow without troubleshooting every run."
— Senior Scientist, Immunology Discovery Team
"Our first alginate microgel attempts were rough on cells and the gels weren't consistent. The Creative Biolabs team redesigned the gelation strategy and tuned the on-chip timing so gelation happened predictably without exposing cells to harsh conditions."
— Project Lead, Biomaterials & Microphysiology Group
"Creative Biolabs designed the workflow around recovery from the start—demulsification considerations, wash steps, and practical notes to prevent cell loss. The final protocol was easy for different operators to run, and we reliably recovered viable cells for expansion and follow-up assays."
— Director, Cell Screening & Analytics
"Our pain point was run-to-run variability and droplet drift during longer experiments. The team optimized surfactant/oil compatibility and wettability controls and established QC checkpoints we could verify in minutes. The result was a stable droplet size distribution across extended runs."
— Staff Engineer, Microfluidics Development
Single-cell encapsulation in droplet microfluidics
The researchers introduced a novel droplet microfluidic chip. The chip comprises a double spiral focusing unit, a flow resistance-based sample enrichment module with fine-tunable outlets, and a crossflow droplet generation unit. Utilizing a low-density cell/bead suspension, cells/beads are focused into a near-equidistant linear arrangement within the double spiral microchannel. The excess water phase is diverted while cells/beads remain focused and sequentially encapsulated in individual droplets.
Fig.1 Schematic representation of the microfluidic platform.1,2
References
Created January 2026
A: Yes. We design around gentle handling: flow regime selection, channel geometry to minimize shear hotspots, anti-clumping preparation steps, and stability conditions that avoid prolonged exposure to reactive or stressful chemistry. Where hydrogel microgels are used, we prioritize triggered gelation strategies that reduce harsh conditions linked to viability loss.
A: We optimize loading density and flow parameters and can introduce design strategies that improve effective single-cell capture. We also help you define the practical acceptance window (single occupancy vs empty droplets vs doublets) based on your downstream readout, and we can plan enrichment strategies if needed.
A: Yes. Alginate microgels are a common choice, and we can implement triggered gelation approaches that improve biocompatibility. Literature on on-chip triggered gelation for alginate microgels provides a strong technical foundation for these workflows.
A: Throughput depends on droplet size, generator design, and stability constraints. Foundational demonstrations report rates up to several hundred Hz for encapsulation/handling in picoliter droplets, and we architect systems to meet your practical throughput target without compromising stability or cell health.
A: We evaluate surfactant/oil compatibility, wetting control, and handling steps that often cause coalescence (temperature shifts, agitation, transfers). Stability is engineered, not assumed—so we validate it under your real incubation and assay conditions.
A: Cell type and condition, desired encapsulation format (single-cell vs multicell, droplet vs microgel), incubation time, assay readout, throughput goal, and whether recovery is required. If you already have preferred oils/surfactants or constraints on materials (e.g., optical clarity), include those as well.
If you share your cell type, desired encapsulation format, incubation time, and readout, our team will map the fastest route to a stable, reproducible microfluidic encapsulation workflow—then translate it into a build-and-run solution your lab can use with confidence.